Marksans Pharma is currently trading at Rs. 53.00, up by 1.45 points or 2.81% from its previous closing of Rs. 51.55 on the BSE.
The scrip opened at Rs. 52.25 and has touched a high and low of Rs. 53.60 and Rs. 50.75 respectively. So far 5,97,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 58.30 on 06-Oct-2016 and a 52 week low of Rs. 36.95 on 01-Feb-2017.
Last one week high and low of the scrip stood at Rs. 54.00 and Rs. 49.65 respectively. The current market cap of the company is Rs. 2,169.36 crore.
The promoters holding in the company stood at 48.25%, while Institutions and Non-Institutions held 8.63% and 43.12% respectively.
Marksans Pharma has received certificate of GMP Compliance of a Manufacturer from Australian government, Department of Health, Therapeutic Goods Administration for its manufacturing facility located at L-82 & L-83, Verna Industrial Estate, Verna, Goa.
Marksans Pharma is engaged in production of prescription drugs, caters in areas like oncology, gastroenterology, antidiabetic, cardiovascular, pain management, gynaecology and others.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1620.50 |
Dr. Reddys Lab | 6171.85 |
Cipla | 1494.65 |
Zydus Lifesciences | 1013.75 |
Lupin | 1617.85 |
View more.. |